InGeneron Launches Study for Rotator Cuff Tendinopathy Therapy

InGeneron enrolled the first patients in a pivotal study evaluating autologous adipose-derived regenerative cells for the treatment of partial thickness rotator cuff tears involving the supraspinatus tendon.

The primary goal of the double-blinded, multi-center trial is to demonstrate the effectiveness of this point-of-care cell therapy. The...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us